Annual Accounts Payable
$616.00 K
-$773.00 K-55.65%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual accounts payable is $616.00 thousand, with the most recent change of -$773.00 thousand (-55.65%) on December 31, 2023.
- During the last 3 years, TCRT annual accounts payable has fallen by -$344.00 thousand (-35.83%).
- TCRT annual accounts payable is now -86.05% below its all-time high of $4.42 million, reached on December 31, 2017.
Performance
TCRT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$458.00 K
+$93.00 K+25.48%
September 30, 2024
Summary
- As of February 7, 2025, TCRT quarterly accounts payable is $458.00 thousand, with the most recent change of +$93.00 thousand (+25.48%) on September 30, 2024.
- Over the past year, TCRT quarterly accounts payable has increased by +$93.00 thousand (+25.48%).
- TCRT quarterly accounts payable is now -89.63% below its all-time high of $4.42 million, reached on December 31, 2017.
Performance
TCRT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TCRT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.6% | +25.5% |
| 3 y3 years | -35.8% | -68.7% |
| 5 y5 years | -12.9% | -82.5% |
TCRT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | at low | -76.9% | +25.5% |
| 5 y | 5-year | -55.6% | at low | -89.1% | +25.5% |
| alltime | all time | -86.0% | >+9999.0% | -89.6% | >+9999.0% |
Alaunos Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $458.00 K(+25.5%) |
| Jun 2024 | - | $365.00 K(-38.9%) |
| Mar 2024 | - | $597.00 K(-3.1%) |
| Dec 2023 | $616.00 K(-55.7%) | $616.00 K(-52.5%) |
| Sep 2023 | - | $1.30 M(-12.2%) |
| Jun 2023 | - | $1.48 M(+7.2%) |
| Mar 2023 | - | $1.38 M(-0.6%) |
| Dec 2022 | $1.39 M(+1.5%) | $1.39 M(-30.0%) |
| Sep 2022 | - | $1.98 M(+318.6%) |
| Jun 2022 | - | $474.00 K(-21.7%) |
| Mar 2022 | - | $605.00 K(-55.8%) |
| Dec 2021 | $1.37 M(+42.5%) | $1.37 M(-6.5%) |
| Sep 2021 | - | $1.46 M(+49.0%) |
| Jun 2021 | - | $982.00 K(-76.6%) |
| Mar 2021 | - | $4.19 M(+336.5%) |
| Dec 2020 | $960.00 K(+6.0%) | $960.00 K(-63.3%) |
| Sep 2020 | - | $2.62 M(+142.1%) |
| Jun 2020 | - | $1.08 M(+173.2%) |
| Mar 2020 | - | $396.00 K(-56.3%) |
| Dec 2019 | $906.00 K(+28.1%) | $906.00 K(-2.2%) |
| Sep 2019 | - | $926.00 K(-1.6%) |
| Jun 2019 | - | $941.00 K(+9.5%) |
| Mar 2019 | - | $859.00 K(+21.5%) |
| Dec 2018 | $707.00 K(-84.0%) | $707.00 K(-44.3%) |
| Sep 2018 | - | $1.27 M(+115.8%) |
| Jun 2018 | - | $588.00 K(-3.0%) |
| Mar 2018 | - | $606.00 K(-86.3%) |
| Dec 2017 | $4.42 M(+2731.4%) | $4.42 M(+189.8%) |
| Sep 2017 | - | $1.52 M(+1781.5%) |
| Jun 2017 | - | $81.00 K(-64.2%) |
| Mar 2017 | - | $226.00 K(+44.9%) |
| Dec 2016 | $156.00 K(-92.2%) | $156.00 K(-91.4%) |
| Sep 2016 | - | $1.81 M(-10.7%) |
| Jun 2016 | - | $2.03 M(+6.4%) |
| Mar 2016 | - | $1.91 M(-5.0%) |
| Dec 2015 | $2.01 M(+0.2%) | $2.01 M(-51.7%) |
| Sep 2015 | - | $4.15 M(+32.2%) |
| Jun 2015 | - | $3.14 M(+303.5%) |
| Mar 2015 | - | $779.00 K(-61.1%) |
| Dec 2014 | $2.00 M(+374.9%) | $2.00 M(+2.6%) |
| Sep 2014 | - | $1.95 M(+336.9%) |
| Jun 2014 | - | $447.00 K(-22.7%) |
| Mar 2014 | - | $578.00 K(+37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $422.00 K(-72.0%) | $422.00 K(-52.6%) |
| Sep 2013 | - | $891.00 K(-23.5%) |
| Jun 2013 | - | $1.17 M(+18.5%) |
| Mar 2013 | - | $983.00 K(-34.9%) |
| Dec 2012 | $1.51 M(-12.6%) | $1.51 M(-64.5%) |
| Sep 2012 | - | $4.25 M(+189.0%) |
| Jun 2012 | - | $1.47 M(-25.9%) |
| Mar 2012 | - | $1.98 M(+14.9%) |
| Dec 2011 | $1.73 M(+67.5%) | $1.73 M(-20.0%) |
| Sep 2011 | - | $2.16 M(+21.1%) |
| Jun 2011 | - | $1.78 M(-3.7%) |
| Mar 2011 | - | $1.85 M(+79.7%) |
| Dec 2010 | $1.03 M(-42.4%) | $1.03 M(-5.2%) |
| Sep 2010 | - | $1.09 M(-4.8%) |
| Jun 2010 | - | $1.14 M(-22.1%) |
| Mar 2010 | - | $1.47 M(-17.9%) |
| Dec 2009 | $1.79 M(-32.2%) | $1.79 M(+14.8%) |
| Sep 2009 | - | $1.56 M(-2.9%) |
| Jun 2009 | - | $1.61 M(-0.9%) |
| Mar 2009 | - | $1.62 M(-38.6%) |
| Dec 2008 | $2.64 M(-9.3%) | $2.64 M(+18.5%) |
| Sep 2008 | - | $2.23 M(+17.2%) |
| Jun 2008 | - | $1.90 M(-28.2%) |
| Mar 2008 | - | $2.65 M(-9.0%) |
| Dec 2007 | $2.91 M(+274.8%) | $2.91 M(+77.6%) |
| Sep 2007 | - | $1.64 M(+10.0%) |
| Jun 2007 | - | $1.49 M(+55.8%) |
| Mar 2007 | - | $955.70 K(+23.1%) |
| Dec 2006 | $776.10 K(-7.2%) | $776.10 K(-32.1%) |
| Sep 2006 | - | $1.14 M(+82.4%) |
| Jun 2006 | - | $627.10 K(+15.1%) |
| Mar 2006 | - | $544.90 K(-34.8%) |
| Dec 2005 | $836.00 K(+17.8%) | $836.00 K(+75.1%) |
| Sep 2005 | - | $477.40 K(+4722.2%) |
| Jun 2005 | - | $9900.00(-5.7%) |
| Mar 2005 | - | $10.50 K(-98.5%) |
| Dec 2004 | $709.90 K(+9240.8%) | $709.90 K(>+9900.0%) |
| Sep 2004 | - | $5300.00(+17.8%) |
| Jun 2004 | - | $4500.00(-40.8%) |
| Mar 2004 | - | $7600.00(0.0%) |
| Dec 2003 | $7600.00(+1166.7%) | $7600.00(+1166.7%) |
| Mar 2003 | - | $600.00(0.0%) |
| Dec 2002 | $600.00 | $600.00 |
FAQ
- What is Alaunos Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual accounts payable year-on-year change?
- What is Alaunos Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly accounts payable year-on-year change?
What is Alaunos Therapeutics annual accounts payable?
The current annual accounts payable of TCRT is $616.00 K
What is the all time high annual accounts payable for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual accounts payable is $4.42 M
What is Alaunos Therapeutics annual accounts payable year-on-year change?
Over the past year, TCRT annual accounts payable has changed by -$773.00 K (-55.65%)
What is Alaunos Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TCRT is $458.00 K
What is the all time high quarterly accounts payable for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly accounts payable is $4.42 M
What is Alaunos Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TCRT quarterly accounts payable has changed by +$93.00 K (+25.48%)